Cytochrome P450 (P450) enzymes are the major catalysts involved in the metatiolism of carcinogens, drugs, and steroids. Variations in the catalytic activities have a variety of effects in homeostasis and clinical practice. Continued studies on human P450s are proposed, with a focus on molecular understanding of function. (1) Of the 57 human P450 genes, 13 still have limited if any knowledge regarding function. We propose to establish sites of mRNA expression, express these "orphan" P450s in heterologous systems, and examine their abilities to activate a wide variety of chemical carcinogens. In addition, several HPLC-mass spectrometry approaches will be used for identification of products and substrates, with tissue extracts as sources of substrates and the P4SOs as reagents. This part of the project is an effort towards understanding the functional genomics of human P450s. A related aspect is establishment of the roles of individual human P450s in morphine biosynthesis, forwhich strong evidence has been recently presented by others. (2) Comparisons of the Idnetics of human P450s already studied in detail (1A2, 2A6, 2D6,2E1, 3A4) will be done with several other P450s reported to have much higher rates of catalysis, with the goal of understanding which steps limit the (human P4S0) reactions. These studies will involve a variety of steady-state, pre-steady-state, and isotope effect approaches. (3) Kinetic analysis of multi-reaction P450s will be done, including P450S 51Al (ianosterol 14a-demethylation), 19A1 (aromatase, oxidation of testosterone to 17p-estradiol), and 2A6 (oxidation of indoles), wrth a goal of defining the processivity of these systems. Several pre-steady-state and analysis approaches can be readily applied to the problem, with the goal of understanding the release of intermediates. (4) P450S 3A4 and 2A6 will be analyzed regarding hypotheses about cooperativity and induced fit in substrate binding and catalysis. The P450 3A4 work will focus on pre-steady-state i^inetics of substrate binding, along with thermodynamic analysis of binding. The work on P4S0 2A6 induced fit will involve collaborative work on X-ray crystallography of mutants that have demonstrated expansion of the active site. These results should reveal whether a P450 has a fixed structure or can "adapt" to individual substrates, Collectively, these studies have the goal of providing more understanding of the roles of human P450s in oxidation of drugs, carcinogens, and endogenous compounds and their potential contributions to cancer and other diseases and roles in disease treatments.
The P450 enzymes are the main catalysts involved in the metabolism of carcinogens and daigs, and the balance between bioactivation (to dangerous products) and detoxication is important in health issues and also varies among individuals. Many of the biochemical properties of some human P450s are pooriy understood, and several of these enzymes are postulated to have important roles in chemical carcinogenesis.
|Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy et al. (2014) Targeting of splice variants of human cytochrome P450 2C8 (CYP2C8) to mitochondria and their role in arachidonic acid metabolism and respiratory dysfunction. J Biol Chem 289:29614-30|
|Yoshimoto, Francis K; Guengerich, F Peter (2014) Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase. J Am Chem Soc 136:15016-25|
|Bansal, Seema; Leu, Adrian N; Gonzalez, Frank J et al. (2014) Mitochondrial targeting of cytochrome P450 (CYP) 1B1 and its role in polycyclic aromatic hydrocarbon-induced mitochondrial dysfunction. J Biol Chem 289:9936-51|
|Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K et al. (2014) Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1. J Biol Chem 289:10476-87|
|Chowdhury, Goutam; Shibata, Norio; Yamazaki, Hiroshi et al. (2014) Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide. Chem Res Toxicol 27:147-56|
|Murayama, Norie; van Beuningen, Rinie; Suemizu, Hiroshi et al. (2014) Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor. Chem Res Toxicol 27:304-8|
|Kim, Donghak; Cha, Gun-Su; Nagy, Leslie D et al. (2014) Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11. Biochemistry 53:6161-72|
|Goyal, Sandeep; Xiao, Yi; Porter, Ned A et al. (2014) Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1. J Lipid Res 55:1933-43|
|Guengerich, F Peter (2014) Thematic minireview series: metals in biology 2014. J Biol Chem 289:28094|
|Okubo, Maho; Murayama, Norie; Shimizu, Makiko et al. (2013) CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes. J Toxicol Sci 38:349-54|
Showing the most recent 10 out of 79 publications